The Citrate Story
David Gattas gives an update on today’s go-to anti-coagulant for renal replacement therapy: Citrate
David is a key figure in the ANZICS CTG, with a growing list of publications, and was an investigator for the The Heparin Citrate study.
Follow David on Twitter here
This talk was recorded live at an ICN NSW / ANZICS meeting in September 2014.
[/az_box_icon]
[/az_box_icon]